Advertisement

PHR

Phreesia, Inc.

Healthcare · USD

Set alert

Price alert · PHR

All alert types
12.44 USD -0.09 -0.72%
As of Oct 30, 2026 Extended hours 12.44 0.00%
Bid
12.40 × 400
Ask
12.48 × 200
12.20 Day range 12.79
8.06 52-week range 23.15
YTD
-26.48%
1 year
-45.10%
Open
12.59
Prev close
12.53
Mkt cap
772.16M
Vol
597.73K
Avg vol
734.77K
EPS
0.17
P/E
73.18
Div yield
0.00%
More statistics
Low
12.20
High
12.79
Forward P/E
-25.76
Beta
0.64
Short ratio
7.35
Inst. own
104.22%
Dividend
0.00
Ex-div date
50-d avg
22.08
200-d avg
25.25
1y target
32.47

5D chart

Chart tools
Interval
PHR five-day price chart12.112.312.512.712.8Oct 26Oct 27Oct 28Oct 29Oct 30

Key statistics

Market cap
925.98M
Enterprise value
788.45M
Trailing P/E
0.00
Forward P/E
-25.76
PEG ratio
0.00
Price / sales
2.06
Price / book
3.10
EPS (TTM)
-0.42
Beta
0.64
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
-5.35%
Revenue (TTM)
449.67M
Revenue growth
45.70%
Free cash flow
36.91M
Total cash
439.85M
Total debt
12.64M
Return on equity
-8.76%
Shares outstanding
59.91M
Short % of float
5.99%
50-day average
22.08
200-day average
25.25

Analyst view

Consensus: strong buy

Strong buy
Price target (mean) 32.47 +161.0% upside
Target (low)
26.00
Target (mean)
32.47
Target (high)
36.00
Ratings (0m) 18 18 buy · 0 hold · 0 sell
  • Strong buy6
  • Buy12
  • Hold0
  • Sell0
  • Strong sell0

Next earnings

Consensus EPS estimate 0.36.

Earnings history

Financials — quick view

All financials
PHR Revenue — quarterly 129.46M
2023-Q3 20222023-Q4 20222024-Q1 20232024-Q2 20232024-Q3 20232024-Q4 20232025-Q1 20242025-Q2 20242025-Q3 20242025-Q4 20242026-Q1 20252026-Q2 20252026-Q3 20252026-Q4 20252027-Q1 20262027-Q2 2026
PHR Net income — quarterly 1.92M
2023-Q3 20222023-Q4 20222024-Q1 20232024-Q2 20232024-Q3 20232024-Q4 20232025-Q1 20242025-Q2 20242025-Q3 20242025-Q4 20242026-Q1 20252026-Q2 20252026-Q3 20252026-Q4 20252027-Q1 20262027-Q2 2026
PHR EPS — quarterly 0.03
2023-Q3 20222023-Q4 20222024-Q1 20232024-Q2 20232024-Q3 20232024-Q4 20232025-Q1 20242025-Q2 20242025-Q3 20242025-Q4 20242026-Q1 20252026-Q2 20252026-Q3 20252026-Q4 20252027-Q1 20262027-Q2 2026

Earnings

PHR recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Dec 8, 2025Oct 1, 2025—0.10——
Sep 4, 2025Jul 1, 2025—0.01+0.08+114.29%

Upgrades / downgrades

PHR analyst upgrades and downgrades
DateFirmActionFromTo
Dec 9, 2025CitigroupmainBuyBuy
Dec 9, 2025NeedhamreitBuyBuy
Dec 9, 2025Canaccord GenuitymainBuyBuy
Dec 9, 2025JP MorganmainOverweightOverweight
Dec 9, 2025Barclaysinit—Overweight
Dec 8, 2025NeedhamreitBuyBuy

About Phreesia, Inc.

Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers an appointment scheduling system for online appointments, reminders, and referral tracking and management; registration solutions to automate patient self-registration; revenue cycle solutions that provide insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network solutions to deliver clinically relevant content to patients. It deploys its platform in a range of modalities, including Phreesia Mobile, a patients' mobile device; PhreesiaPads, a self-service intake tablets; Phreesia Dashboard, a web-based dashboard for healthcare services clients; and Arrivals Kiosks, which are on-site kiosks. The company serves a range of healthcare services clients, including single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies, as well as government entities and other organizations. Phreesia, Inc. was incorporated in 2005 and is based in Wilmington, Delaware.

Sector
Healthcare
Industry
Health Information Services
Country
United States
Website
phreesia.com

News

Your note

Sign in to keep a note on PHR — it syncs with the Stock Master app.

Insider holders

PHR insider holders
InsiderRelationLatest transactionDateShares held
CAHILL EDWARD LDirectorStock Award(Grant)Oct 30, 202563,784
GANDHI BALAJIChief Financial OfficerSaleOct 16, 202598,240
GOLDSTEIN LAINIEDirectorStock Award(Grant)Oct 30, 202549,366
HOFFMAN ALLISON CGeneral CounselSaleOct 16, 2025135,737
HUI YVONNEOfficerSaleOct 14, 202530,336
INDIG CHAIM EDWARDSChief Executive OfficerSaleOct 16, 20251,507,610

Institution ownership

PHR institution ownership
Holder% heldSharesValueReported
Vanguard Group Inc9.52%5,704,78688.17MSep 29, 2025
Blackrock Inc.9.50%5,692,73687.98MSep 29, 2025
FMR, LLC6.54%3,919,08460.57MSep 29, 2025
Greenhouse Funds, LLLP6.48%3,882,52760.00MSep 29, 2025
Capital International Investors5.23%3,134,87248.45MSep 29, 2025
Champlain Investment Partners, LLC4.47%2,678,82541.40MSep 29, 2025

Fund ownership

PHR fund ownership
Holder% heldSharesValueReported
SmallCap World Fund Inc5.23%3,134,87248.45MSep 29, 2025
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund2.93%1,753,74827.10MSep 29, 2025
iShares Trust-iShares Russell 2000 ETF2.38%1,427,48822.06MSep 29, 2025
Franklin Strategic Series-FRANKLIN SMALL CAP GROWTH FUND2.13%1,278,70619.76MJul 30, 2025
Old Westbury Funds Inc-Old Westbury Small & Mid Cap Strategies Fund1.86%1,115,06317.23MJul 30, 2025
Fidelity Select PORT.s-Select Medical Technology and Devices PORT.1.80%1,080,00016.69MSep 29, 2025
Advertisement